Skip to main content

Table 2 Lymph node status of the non-bursectomy group and the bursectomy group

From: Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China

Characteristics Non-bursectomy group Bursectomy group p value
N = 247 (%) N = 159 (%)
T stage    0.136
 T2 48 (19.4) 20 (12.6)  
 T3 45 (18.2) 37 (23.3)  
 T4 154 (62.3) 102 (64.2)  
N stage    0.593
 N0 60 (24.3) 38 (23.9)  
 N1 51 (20.6) 25 (15.7)  
 N2 43 (17.4) 28 (17.6)  
 N3 93 (37.7) 68 (42.8)  
TNM stage    0.724
 Ib 17 (6.9) 8 (5.0)  
 IIa 24 (9.7) 16 (10.1)  
 IIb 45 (18.2) 30 (18.9)  
 IIIa 47 (19.0) 22 (13.8)  
 IIIb 42 (17.0) 30 (18.9)  
 IIIc 72 (29.1) 53 (33.3)  
No.4D LNs    
 Number of positive 0.7 ± 1.3 0.8 ± 1.8 0.675
 Number of examined 3.7 ± 2.7 4.9 ± 4.0 0.001
No.4SB LNs    
 Number of positive 0.1 ± 0.5 0.1 ± 0.8 0.617
 Number of examined 1.7 ± 2.2 1.6 ± 2.3 0.743
No.6 LNs    
 Number of positive 1.2 ± 2.0 0.9 ± 1.7 0.158
 Number of examined 4.4 ± 3.4 4.8 ± 3.8 0.362
Total    
 Number of positive 5.9 ± 6.4 7.5 ± 8.7 0.045
 Number of examined 25.4 ± 9.9 40.6 ± 17.5 <0.001
  1. LNs lymph nodes